From Access to Adherence: The Challenges of Antiretroviral Treatment - Studies from Botswana, Tanzania and Uganda, 2006
(2006; 320 pages) Ver el documento en el formato PDF
Índice de contenido
Ver el documentoAcknowledgments
Ver el documentoAcronyms and abbreviations
Ver el documentoForeword
Abrir esta carpeta y ver su contenido1. On hunger, transport costs and waiting time: a synthesis of challenges to ARV adherence in three African countries
Abrir esta carpeta y ver su contenido2. Overview of antiretroviral therapy, adherence and drug-resistance
Abrir esta carpeta y ver su contenido3. From training to action: the process of engaging health professionals in operational research on adherence to antiretroviral therapy
Ver el documento4. There's hope - early observations of ARV treatment roll-out in South Africa
Abrir esta carpeta y ver su contenidoFactors that facilitate or constrain adherence to antiretroviral therapy among adults at four public health facilities in Botswana: a pre-intervention study
Abrir esta carpeta y ver su contenidoA study on antiretroviral adherence in Tanzania: a pre-intervention perspective, 2005
Cerrar esta carpetaFactors that facilitate or constrain adherence to antiretroviral therapy among adults in Uganda: a pre-intervention study
Ver el documentoAcknowledgements
Ver el documentoGlossary
Ver el documentoExecutive summary
Cerrar esta carpetaChapter 1: Introduction
Ver el documento1.1 Background
Ver el documento1.2 Research problem
Ver el documento1.3 Research objective
Abrir esta carpeta y ver su contenidoChapter 2: Background to the study
Abrir esta carpeta y ver su contenidoChapter 3: Literature review
Abrir esta carpeta y ver su contenidoChapter 4: Methodology
Abrir esta carpeta y ver su contenidoChapter 5: Description of the study sites
Abrir esta carpeta y ver su contenidoChapter 6: Results
Abrir esta carpeta y ver su contenidoChapter 7: Discussion, conclusions and recommendations
Ver el documentoReferences
Ver el documentoBack cover
 

1.2 Research problem

In Uganda, there is growing concern about loss to follow-up and sub-optimal adherence to ART as significant barriers to care (Kityo et al., 2002). Although Uganda is described in most literature as a success story to emulate in sub-Saharan Africa (Green, 2003), there was a need to assess the quality of care and adherence among people receiving these life-extending medicines. Since the service was newly introduced, it was vital that studies be conducted to evaluate and assess levels of adherence among people on ART and factors affecting adherence in both private and public facilities. Such studies would help inform the MoH and other policy-makers in Uganda on ways of improving or maintaining adherence to ART as access to ARV medicines is scaled up nationwide.

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 3 mayo 2013